Inventor · disambiguated record
Kristine De Dios
Also filed as: DE DIOS KRISTINE
10 granted patents·2 pending applications·97 citations·filing 2011–2023
90Inventor score
Top patents by PatentIndex Score
12 records- 0196US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 0295US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 0395US8735539B2Relaxin polypeptides comprising non-naturally encoded amino acidsKRAYNOV VADIM·Filed 2011·Granted May 27, 2014·36 cites·58 claims
- 0494US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 0594US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 0692US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 0791US9452222B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2014·Granted Sep 27, 2016·14 cites·19 claims
- 0887US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 0981US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 1081US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
- 1173US11311605B2Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 1272US11439710B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Sep 13, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Kristine De Dios files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →